Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0356920090570040472
Korean Journal of Anesthesiology
2009 Volume.57 No. 4 p.472 ~ p.482
Effects of ATP and LTC4 on hypoxic pulmonary vasoconstriction in isolated rat lungs
Rho Ji-Yoon

Shin Hwa-Yong
Kim Hyun-Chang
Lee Ji-Won
Kim Seong-Deok
Abstract
Background: Hypoxic pulmonary vasoconstriction (HPV) is unique to pulmonary circulation but the mechanism remains elusive. Red blood cells (RBCs) are known to augment HPV and to release more ATP as oxygen content falls. Leukotrienes constrict smooth muscle and could be important for the regulation of the pulmonary circulation. Hence we hypothesized that ATP and leukotrienes are mediators of HPV produced during acute alveolar hypoxia.

Methods: In forty Sprague-Dawley rats, lungs were isolated and perfused. We administered ATP (10 ¥ìM) to the ATP group (n = 8), the ATP antagonist, suramin (100 ¥ìM) to the suramin group (n = 8), leukotriene C4 (LTC4, 5 ¥ìg) to the LTC4 group (n = 8), the LTC4 antagonist, LY171883 (20 ¥ìM) to the LY171883 group (n = 8), and LTC4 (5 ¥ìg) + ATP (10 ¥ìM) to the LTC4 + ATP group (n = 8) during normoxic ventilation. HPV responses were induced by three hypoxic challenges for 5 minutes separated by 5 minutes of ventilation with a normoxic gas mixture. Baseline pulmonary artery pressure change after exposure to each drug and hypoxic pressor response between a period 21% normoxic gas ventilation and that of 3% hypoxic gas ventilation were measured.

Results: ATP and LTC4 + ATP increased baseline pulmonary artery pressures but LTC4 did not alter it. ATP did not affect hypoxic pressor response. Suramin, LY171883 and LTC4 + ATP inhibited the pressor response to hypoxia. LTC4 increased hypoxic pressor response.

Conclusions: In isolated rat lungs, HPV may be mediated by ATP and LTC4 appears more likely to be a modulator than a mediator of HPV.
KEYWORD
ATP, Hypoxic pulmonary vasoconstriction, Isolated rat lungs, Leukotriene C4, LY171883, Suramin
FullTexts / Linksout information
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø